Skip to main content
Top
Published in: Journal of Assisted Reproduction and Genetics 12/2017

01-12-2017 | Commentary

At the dawn of personalized reproductive medicine: opportunities and challenges with incorporating multigene panel testing into fertility care

Authors: Piraye Yurttas Beim, David-Emlyn Parfitt, Lei Tan, Elaine A. Sugarman, Tina Hu-Seliger, Caterina Clementi, Brynn Levy

Published in: Journal of Assisted Reproduction and Genetics | Issue 12/2017

Login to get access

Excerpt

Advances in genomics are revolutionizing how diseases are prevented, diagnosed, and treated, across all fields of medicine. In reproductive medicine, genomic technologies are used for carrier, embryo, and prenatal screening. However, to date, genetic information has not been widely utilized for guiding treatment decisions or identifying individuals at risk for reproductive conditions, including those that can lead to infertility and early menopause. In contrast, analysis of genetic biomarkers is now the standard of care in oncology [1]. Today, oncologists routinely categorize tumors based on genetic signatures and refine their treatment strategies accordingly. This targeted approach to more personalized treatment has led to significantly higher progression-free survival rates when compared to the outcomes of conventional therapies [2]. Knowledge of patients’ genetic risk factors has also decreased patient morbidity and mortality by more precisely revealing individuals who would benefit from preventative cancer screenings such as colonoscopies or mammograms. …
Literature
9.
go back to reference Keedy VL, Temin S, Somerfield MR, Beasley MB, Johnson DH, McShane LM, et al. American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy. J Clin Oncol. 2011;29(15):2121–7. https://doi.org/10.1200/JCO.2010.31.8923.CrossRefPubMed Keedy VL, Temin S, Somerfield MR, Beasley MB, Johnson DH, McShane LM, et al. American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy. J Clin Oncol. 2011;29(15):2121–7. https://​doi.​org/​10.​1200/​JCO.​2010.​31.​8923.CrossRefPubMed
14.
go back to reference Willinger M, Hoffman HJ, Hartford RB. Infant sleep position and risk for sudden infant death syndrome: report of meeting held January 13 and 14, 1994, National Institutes of Health, Bethesda, MD. Pediatrics. 1994;93(5):814–9.PubMed Willinger M, Hoffman HJ, Hartford RB. Infant sleep position and risk for sudden infant death syndrome: report of meeting held January 13 and 14, 1994, National Institutes of Health, Bethesda, MD. Pediatrics. 1994;93(5):814–9.PubMed
15.
go back to reference American Academy of Pediatrics Task Force on Sudden Infant Death S. The changing concept of sudden infant death syndrome: diagnostic coding shifts, controversies regarding the sleeping environment, and new variables to consider in reducing risk. Pediatrics. 2005;116(5):1245–55. https://doi.org/10.1542/peds.2005-1499. CrossRef American Academy of Pediatrics Task Force on Sudden Infant Death S. The changing concept of sudden infant death syndrome: diagnostic coding shifts, controversies regarding the sleeping environment, and new variables to consider in reducing risk. Pediatrics. 2005;116(5):1245–55. https://​doi.​org/​10.​1542/​peds.​2005-1499.​ CrossRef
17.
go back to reference Augood C, Duckitt K, Templeton AA. Smoking and female infertility: a systematic review and meta-analysis. Hum Reprod. 1998;13(6):1532–9.CrossRefPubMed Augood C, Duckitt K, Templeton AA. Smoking and female infertility: a systematic review and meta-analysis. Hum Reprod. 1998;13(6):1532–9.CrossRefPubMed
21.
go back to reference Rankin T, Talbot P, Lee E, Dean J. Abnormal zonae pellucidae in mice lacking ZP1 result in early embryonic loss. Development. 1999;126(17):3847–55.PubMed Rankin T, Talbot P, Lee E, Dean J. Abnormal zonae pellucidae in mice lacking ZP1 result in early embryonic loss. Development. 1999;126(17):3847–55.PubMed
Metadata
Title
At the dawn of personalized reproductive medicine: opportunities and challenges with incorporating multigene panel testing into fertility care
Authors
Piraye Yurttas Beim
David-Emlyn Parfitt
Lei Tan
Elaine A. Sugarman
Tina Hu-Seliger
Caterina Clementi
Brynn Levy
Publication date
01-12-2017
Publisher
Springer US
Published in
Journal of Assisted Reproduction and Genetics / Issue 12/2017
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-017-1068-2

Other articles of this Issue 12/2017

Journal of Assisted Reproduction and Genetics 12/2017 Go to the issue